Pharmacokinetics, safety, and efficacy of intravitreal digoxin in preclinical models for retinoblastoma Journal Article
| Authors: | Winter, U.; Buitrago, E.; Mena, H. A.; Del Sole, M. J.; Laurent, V.; Negrotto, S.; Francis, J.; Arana, E.; Sgroi, M.; Croxatto, J. O.; Djaballah, H.; Chantada, G. L.; Abramson, D.; Schaiquevich, P. |
| Article Title: | Pharmacokinetics, safety, and efficacy of intravitreal digoxin in preclinical models for retinoblastoma |
| Abstract: | PURPOSE. To assess in vitro cytotoxic activity and antiangiogenic effect, ocular and systemic disposition, and toxicity of digoxin in rabbits after intravitreal injection as a potential candidate for retinoblastoma treatment. METHODS. A panel of two retinoblastoma and three endothelial cell types were exposed to increasing concentrations of digoxin in a conventional (72-hour exposure) and metronomic (daily exposure) treatment scheme. Cytotoxicity was defined as the digoxin concentration that killed 50% of the cells (IC50) and was assessed with a vital dye in all cell types. Induction of apoptosis and cell-cycle status were evaluated by flow cytometry after both treatment schemes. Ocular and systemic disposition after intravitreal injection as well as toxicity was assessed in rabbits. Electroretinograms (ERGs) were recorded before and after digoxin doses and histopathological examinations were performed after enucleation. RESULTS. Digoxin was cytotoxic to retinoblastoma and endothelial cells under conventional and metronomic treatment. IC50 was comparable between both schedules and induced apoptosis in all cell lines. Calculated vitreous digoxin C<inf>max</inf> was 8.5 lg/mL and the levels remained above the IC50 for at least 24 hours after intravitreal injection. Plasma digoxin concentration was below 0.5 ng/ml. Retinal toxicity was evident after the third intravitreal dose with considerable changes in the ERG and histologic damage to the retina. CONCLUSIONS. Digoxin has antitumor activity for retinoblastoma while exerting antiangiogenic activity in vitro at similar concentrations. Metronomic treatment showed no advantage in terms of dose for cytotoxic effect. Four biweekly injections of digoxin led to local toxicity to the retina but no systemic toxicity in rabbits. © 2015 The Association for Research in Vision and Ophthalmology, Inc. |
| Keywords: | controlled study; histopathology; drug efficacy; drug safety; nonhuman; flow cytometry; animal cell; animal tissue; cell viability; apoptosis; animal experiment; animal model; digoxin; cytotoxicity; retinoblastoma; endothelium cell; biological activity; pharmacokinetics; growth inhibition; electroretinogram; antiangiogenic; cancer; human; priority journal; article; cell cycle assay; electrophysiological procedures |
| Journal Title: | Investigative Ophthalmology & Visual Science (IOVS) |
| Volume: | 56 |
| Issue: | 8 |
| ISSN: | 0146-0404 |
| Publisher: | Association for Research in Vision and Ophthalmology |
| Date Published: | 2015-07-01 |
| Start Page: | 4382 |
| End Page: | 4393 |
| Language: | English |
| DOI: | 10.1167/iovs.14-16239 |
| PROVIDER: | scopus |
| PUBMED: | 26176875 |
| DOI/URL: | |
| Notes: | Export Date: 2 September 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work